Deal type
Regulatory & Antitrust
13 announced Regulatory & Antitrust deals, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 13 Clifford Chance advises U.S. Department of Commerce on US$1 billion CHIPS Act Award to Anderon for quantum semiconductor foundry development 21 Sept 2026
Clifford Chance He Ping advises LB Group on global regulatory filings for acquisition of Venator’s titanium dioxide assets in the UK 25 May 2026
Baker McKenzie Advises Kingspan as First Foreign Investor to Secure Recommendation for State Support under Ukraine’s Significant Investment Law 18 Feb 2026
Hogan Lovells guides Resorts World New York City in securing historic NYC casino license 18 Dec 2025
Latham Represents Fuse Crypto Limited in Securing No-Action Relief From SEC 1 Dec 2025
Latham Advises CHEPLAPHARM on SE Conversion 4 Apr 2024
Clifford Chance advises China Baowu Group on global antitrust filings of its acquisition of equity interest in SD Steel Group 12 Jan 2024
Clifford Chance advises China National Tire & Rubber Corporation, Ltd, a subsidiary of Sinochem, on Italian FDI filing of the renewal shareholders’ agreement concerning the governance of Pirelli & C. S.p.A. 4 Jul 2023
Latham & Watkins Advises MindMed on Successful Proxy Contest Resulting in Election of All Six Company Nominees at Annual Meeting 21 Jun 2023
Latham & Watkins Advises TeamViewer on SE Conversion 18 Mar 2023
European Commission Closes Antitrust Investigation Into Coca-Cola and Its Bottles 2 Mar 2023
Latham & Watkins Advises e.l.f Beauty in Agreement with Marathon Partners 2 Jul 2020
Dentons advises Pro Patria Electronics in its successful bid for a battlefield reconnaissance radars contract 19 Mar 2020